Frias Juan Pablo 4
4 · Biomea Fusion, Inc. · Filed Sep 1, 2023
Insider Transaction Report
Form 4
Frias Juan Pablo
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-08-31+300,000→ 300,000 totalExercise: $16.87Exp: 2033-08-30→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]One-sixteenth (1/16th) of the total number of shares subject to the stock option shall vest and become exercisable at the end of the third month following August 31, 2023 and one-sixteenth (1/16th) of the total number of shares subject to the stock option shall vest and become exercisable quarterly thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.